EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancements in Alzheimer’s Disease Biomarkers: Emerging Protein Targets for Early Diagnosis and Therapeutic Intervention

Mst Muslima Khatun, Most. Israt Jahan Oni, Md. Shadin, B S M Bodiuzzaman

Journal of Medicinal Chemistry and Therapeutics · 2025

DOI: 10.71193/jmct.20250001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry and Therapeutics, 2025. Verfasst von Mst Muslima Khatun und 3 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and neuronal loss. The identification of reliable biomarkers is crucial for early diagnosis and therapeutic intervention. This study explores an insight into current strategies and future approaches for improvement of the treatment, diagnosis, or prevention of AD. AD relevant data were collected from databases like PubMed, Google Scholar, and ScienceDirect. Our study findings reveal that traditional biomarkers such as amyloid-beta (Aβ) and tau proteins remain central to AD pathology, but emerging targets, including neurofilament light chain (NfL), triggering receptor expressed on myeloid cells 2 (TREM2), and synaptic proteins, are gaining attention for their diagnostic and prognostic value. Additionally, lipid peroxidation markers (4-HNE, MDA) and Cytokines (IL-6, TNF-α, and IL-1β) analyses have provided an invasive alternatives for disease monitoring. These advancements facilitate the development of precision medicine approaches, including targeted therapies aimed at modulating key pathological proteins.

Zitieren

APA

Khatun, M. M., Oni, M. I. J., Shadin, M., & Bodiuzzaman, B. S. M. (2025). Advancements in Alzheimer’s Disease Biomarkers: Emerging Protein Targets for Early Diagnosis and Therapeutic Intervention. Journal of Medicinal Chemistry and Therapeutics. https://doi.org/10.71193/jmct.20250001

Vancouver

Khatun MM, Oni MIJ, Shadin M, Bodiuzzaman BSM. Advancements in Alzheimer’s Disease Biomarkers: Emerging Protein Targets for Early Diagnosis and Therapeutic Intervention. Journal of Medicinal Chemistry and Therapeutics. 2025. doi:10.71193/jmct.20250001

BibTeX
@article{Khatun2025,
  author = {Khatun, Mst Muslima and Oni, Most. Israt Jahan and Shadin, Md. and Bodiuzzaman, B S M},
  title = {Advancements in Alzheimer’s Disease Biomarkers: Emerging Protein Targets for Early Diagnosis and Therapeutic Intervention},
  journal = {Journal of Medicinal Chemistry and Therapeutics},
  year = {2025},
  doi = {10.71193/jmct.20250001}
}
Kostenlos starten →